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Abstract 
In recent years chemical biology has been used to engineer ligand-dependent activity into 
enzymes to control a variety of signaling pathways, such as modulating protein production, 
degradation, and localization. These successes have generally incorporated a naturally allosteric 
domain to an enzyme of interest. Here, we demonstrate a novel approach for designing de novo 
allosteric effector sites directly into an enzyme. Our approach diverges from traditional chemical 
rescue in that it does not rely on the disruption and restoration of active site chemistry as a means 
to control enzyme function, but rather on the disruption and restoration of structure. We present 
two examples, W33G in a β-glycosidase enzyme (β-gly) and W492G in a β-glucuronidase 
enzyme (β-gluc), in which we engineer indole-dependent activity into enzymes by removing a 
buried tryptophan sidechain that serves as a buttress for the active site architecture, which results 
in a loss of activity for both enzymes. In both cases we demonstrate that subsequent addition of 
exogenous indole restores catalytic function. We demonstrate through analysis of enzyme 
kinetics that the rescued β-gly W33G enzyme is fully functionally equivalent to that of the wild 
type enzyme. We establish the structural basis for inactivation and rescue by presenting the apo 
and indole-bound crystal structures of β-gly W33G. Finally, we use this rationally designed 
switch to control β-glycosidase activity in living cells with the use of exogenous indole. 
Chemical rescue of protein structure may represent a general approach for designing allosteric 
control into enzymes, and thus may serve as a starting point for building a variety of bioswitches 
and sensors. 
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Introduction 
The use of small molecules to control the activity of re-engineered enzymes is a powerful 
approach that can be used to control cell shape, signal transduction, growth, and survival 1-4. The 
design strategy for introducing pharmacological control into enzymes underlying each of these 
successful examples has been based on the modularity of protein domains 5. By fusing a 
naturally allosteric protein domain to a separate catalytic domain, ligand binding to the effector 
site can affect enzyme activity in select cases 1-4,6. However, screening of multiple domain 
arrangements has been required in these examples to identify the new means of allosteric 
regulation of enzyme activity, which underscores the infeasibility of predicting the detailed 
mechanism of how effector binding results in altered activity 1-4,6. In the case of a naturally 
allosteric single-domain enzyme, elucidating the structural basis for regulation can enable 
introduction of cysteine residues such that activity is dependent on redox conditions that induce 
disulfide bond formation 7. A more general approach involves engineering new catalytic activity 
into a naturally allosteric (non-catalytic) domain 8, but challenges associated with current 
methods of computational enzyme design 9 limit the range of reactions which can be designed in 
this manner, resulting in only a single successful example to date. 
Here we describe a complementary strategy to these approaches.  Rather than utilizing a 
natural allosteric transition, we have instead developed a technique for engineering de novo 
allosteric control into a protein domain that is not naturally allosteric. Our approach is based on 
chemical rescue 10, in which an amino acid sidechain known to be critical for catalysis – often 
histidine – is deleted, leading to loss of enzymatic activity and the creation of an effector binding 
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site. Upon addition of a complementary exogenous ligand – such as imidazole – activity can be 
restored when the small molecule binds to the complementary effector site. Inspired by the 
demonstration that internal protein cavities resulting from mutations can accommodate small 
hydrophobic ligands 11,12, here we propose an alternate approach to chemical rescue. Rather than 
remove a surface sidechain required for catalysis, we instead remove a buried element required 
for structure. Our approach consists of removing a buried structural element in the enzyme, 
which in turn distorts the active site geometry and results in loss of function; subsequent 
exogenous replacement of the complementary small molecule can then be used to restore 
structure, and hence activity (Figure 1a). The ability of an effector ligand to restore protein 
activity will require not simply binding, but also precise rescue of structure. Previous attempts to 
rescue cavity-forming mutants with activating ligands have included a zinc finger transcription 
factor 13 and a hormone-receptor pair 14. Each of these studies identified a rescuing ligand by 
screening restricted compound libraries, and demonstrated that the selected ligand restored 
partial activity. In neither case was activity fully restored, however; we propose that complete 
rescue requires a ligand with exquisite structural complementarity unlikely to be found in a 
screening library of limited size. We expect that complete rescue of function will require exact 
ligand-cavity complementarity, which we attain by rationally matching the effector ligand to the 
structure of the deleted moiety. 
Though this approach may in principle be applied to a deleted structural element 
corresponding to sidechains from multiple amino acid residues, in this study we focus on 
mutation of a single buried tryptophan residue to glycine (WG). If this tryptophan sidechain is 
serving as a structural “buttress” to prevent collapse of the enzyme active site, its removal will 
lead to distortion of the catalytic geometry and thus loss of enzyme activity. Replacement of the 
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buttress via addition of exogenous indole – which perfectly complements the deleted sidechain – 
will restore the original protein conformation, and thus rescue catalytic activity. Critically, the 
mutation site need not be at the active site. If the structural disruption caused by the remote 
mutation is transduced to the active site, the recovery of structure upon complementation is also 
expected to be transduced to the active site through allosteric activation. This approach therefore 
represents a rational strategy for designing remote de novo allosteric effector binding sites into 
proteins. 
Materials and Methods 
Protein expression and purification 
Full-length (untagged) recombinant wild type Sulfolobus solfataricus β-glycosidase 
(β-gly) was expressed from a pET29 vector in E. coli Rosetta(DE3)pLysS cells at 37°C for 4 
hours. The cells were resuspended in Lysis Buffer (50 mM sodium phosphate pH 6.8) and lysed 
with three freeze-thaw cycles. The cell lysate was centrifuged, and the supernatant was incubated 
at 75°C for 30 min. The aggregated cellular proteins were cleared by centrifugation at 27,000g 
for 30 min, leaving the β-gly in the supernatant, which was then further purified by HPLC using 
a HiLoad 16/60 Superdex 75 gel filtration column (GE Healthcare). The purified enzyme was 
pooled and dialyzed against β-gly Enzyme Assay Buffer (50 mM Sodium Phosphate pH 6.5). 
Full length hexahistidine-tagged recombinant wild type Escherichia coli β-glucuronidase 
(β-gluc) was expressed from a pET28a vector in E. coli Rosetta 2(DE3)pLysS cells at 15ºC 
overnight. The cells were resuspended in Lysis Buffer (50 mM Tris, 150 mM NaCl, 5 mM 
imidazole pH 8.0) and sonicated for two minutes (Fisher Scientific Sonic Dismembrator Model 
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100). The cell lysates were then centrifuged at 22,000g for 30 min. The β-gluc remained in the 
supernatant, which was purified by HPLC affinity chromatography with Ni-chelated Sepharose 
Fast Flow Resin (GE Healthcare), followed by a HiLoad 16/60 Superdex 75 gel filtration column 
(GE Healthcare). The purified enzyme was pooled and dialyzed against β-gluc Enzyme Assay 
Buffer (50 mM sodium phosphate pH 7.4, 100 mM NaCl). All protein concentrations were 
determined with reference to bovine albumin standards using Bradford assays. Point mutations 
were introduced using the QuikChange methodology (Stratagene), and mutant proteins were 
purified as described for the corresponding wild-type protein. 
Assays of enzyme kinetics 
β-glycosidase assays were carried out at 37°C in 100 μL reactions in black 96-well 
plates. Each reaction contained 58 nM β-gly in Enzyme Assay Buffer (50 mM sodium phosphate 
pH 6.5), and indole concentrations ranging from 0 to 10 mM in 5% DMSO. Duplicate reactions 
were initiated by addition of 20 μL substrate fluorescein di-β-D-galactopyranoside (FDG) 
dissolved in 0.1% ethanol, 0.1% DMSO, and 99.8% water. FDG concentrations ranged from 1 to 
750 μM for complete kinetic analysis (Figure 2), but were held fixed at 100 μM for initial 
evaluation of rescue (Figure 1). β-glycosidase cleaves FDG twice to yield one molecule of D-
galactose and two molecules of fluorescein. Product formation (fluorescein) was continuously 
monitored for 15 min by fluorescence with an excitation filter of 485nm and an emission filter of 
528nm using a Synergy 2 Microplate reader (Biotek). Initial velocities were calculated by linear 
regression using Microsoft Excel, and apparent Michaelis-Menten parameters were determined 
by direct fitting of the data to the Michaelis-Menten equation using KaleidaGraph. Fitting the 
allosteric rate equation to obtain the enzyme-indole dissociation constant was carried out with 
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C++ code invoking the GSL multidimensional minimization tools (http://www.gnu.org/s/gsl/). 
Source code to carry out this fitting will be freely provided upon request. 
β-glucuronidase assays were carried out at 30ºC in 100 μL reactions in clear 96-well 
plates. Each reaction contained final concentrations of 40 mM 2-nitrophenyl-β-
D-glucopyranoside (ONPGlc), 5% ethanol, 3.7 μM β-gluc in Enzyme Assay Buffer (75 mM 
sodium phosphate pH 7.4, 100 mM NaCl), and indole concentrations ranging from 0 to 10 mM. 
β-glucuronidase cleaves ONPGlc to yield D-glucose and 2-nitrophenol. Product formation 
(ortho-nitrophenol, ONP) was monitored continuously for 30 min by absorbance at 405 nm in a 
Synergy 2 Microplate reader (Biotek). 
Qualitative (X-gal) assay of β-gly rescue in E. coli 
E. coli XL1-Blue cells (Stratagene) were transformed with plasmids encoding either 
wild-type, W33G, or W425G β-gly under control of a lac promoter in the pHG165 vector. Cells 
were grown in 10 mL cultures of LB media supplemented with 100 μg/mL ampicillin at 37°C 
with vigorous shaking to an OD600 of 0.6. Protein expression was induced with 1 mM IPTG for 3 
h. Each cell culture was split into two equal parts; one was supplemented with 2 mM indole and 
0.5% DMSO while the other was supplemented only with 0.5% DMSO. From each culture, a 1 
mL aliquot was removed and supplemented with 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal) to a final concentration of 196 μM. The remainder of the original 
cultures were reserved for further fractionation (Figure S4). All cultures were incubated an 
additional four hours, and photos were taken of the X-gal supplemented cultures. 
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The reserved cultures were then centrifuged to pellet the cells, and the growth media was 
removed. The cells were resuspended and washed in LB media three times, and lysed with three 
freeze-thaw cycles. The media and cell lysate fractions were further divided into equal aliquots, 
one of which was supplemented with indole to a final concentration of 2 mM. All media and cell 
lysate fractions were then supplemented with 196 μM X-gal and incubated for 4 h. 
Quantitative (FDG) assay of β-gly rescue in E. coli 
Cell cultures were grown as described above for the qualitative (X-gal) experiment. After 
3 h of protein expression, cell density (OD600) was normalized for both wild-type and W33G 
β-gly cultures. Each culture was divided into 1 mL aliquots and centrifuged to pellet the cells. 
The cells were resuspended in 1 mL of fresh LB media, then supplemented with either 1.5 mM 
indole and 0.5% DMSO or 0.5% DMSO with no indole. Four independent replicates of each 
culture were grown. 
These cultures were then incubated for one hour at 37°C with vigorous shaking. For each 
1 mL culture, half was removed and supplemented with 15 μM FDG in a volume of 50 μL (0.1% 
ethanol, 0.1% DMSO, and 99.8% water). The other half was supplemented with 50 μL of the 
equivalent buffer (0.1% ethanol, 0.1% DMSO, and 99.8% water) to serve as a blank for the 
fluorescence readings. All samples were incubated in the dark at 37°C with vigorous shaking for 
1 h. From each sample, 100 μL were analyzed using a Synergy 2 Microplate reader (Biotek) in 
black 96-well plates. Fluorescein was detected with an excitation wavelength of 485nm and an 
emission wavelength of 528nm. Fluorescence of the used media in each culture was subtracted 
from the total fluorescence to give the amount of product (fluorescein) inside intact cells. The 
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fraction activity for β-gly W33G relative to wild-type was calculated by dividing the intracellular 
fluorescence between cells treated under analogous conditions. 
Crystal structures of apo and holo β-gly W33G 
Crystal structures for apo and holo β-gly W33G were solved in collaboration with Dr. 
Scott Lovell at the Protein Structure Laboratory at the University of Kansas. 
 β-gly W33G was concentrated to 10.0 mg/mL in HEPES pH 7.0 then screened for 
crystallization in Compact Jr. (Emerald Biosystems) sitting drop vapor diffusion plates. Crystals 
were obtained from the Index screen condition E1 (Hampton Research, 45% 2,-methyl-2,4-
pentanediol, 100 mM bis-tris pH 6.5, 200 mM CaCl2) using equal volumes of protein and 
crystallization solution equilibrated against 100 μL of the latter at 20 oC. Prismatic crystals were 
obtained within 24-48 hours. To prepare the indole-bound complex, single crystals were 
transferred to a drop containing 100 mM indole dissolved in crystallization solution and 
incubated for 1 hour. 
Single crystals of the apo form were transferred to a drop crystallization solution, which 
served as the cryoprotectant, before freezing in liquid nitrogen for data collection.  Crystals 
soaked in the presence of indole were frozen directly from the soaking solution for data 
collection. Data were collected at the Advanced Photon Source IMCA-CAT beamline 17ID 
using a Dectris Pilatus 6M pixel array detector. 
Intensities were integrated and scaled using the XDS 15 and Scala 16 packages 
respectively. Structure solution for unbound β-gly W33G was carried out by molecular 
replacement with Phaser 17 using the isomorphous non-crystallographic dimer of a previously 
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determined lower resolution structure of the W33G mutant (PDB: 3UUJ) as the search model. 
The higher resolution structures reported here were obtained during the revision stages for this 
manuscript.  The earlier PDB entries 3UUJ and 3UUK were therefore withdrawn and replaced 
with the new structures (PDB: 4EAM and 4EAN) for the apo and indole bound structures 
respectively. Structure refinement and manual model building were performed with Phenix 18 and 
Coot 19 respectively. Anisotropic atomic displacement parameters were modeled in the final 
stages of refinement using a TLS model 20. Structure validation was carried out using Molprobity 
21. 
In each structure, large difference density peaks (Fo-Fc) greater than 3σ were observed 
near Arg residues 286, 295 and 440 in each subunit and were originally modeled as water 
molecules. However, following refinement this site was covered with positive electron density 
(Fo-Fc) at a 5σ contour level indicating an underestimation of electrons. Therefore, Cl- ions were 
modeled at these sites and no residual difference density was observed following refinement. 
Electron density consistent with 2-methyl-2,4-pentanediol (MPD) molecules was observed at 
various sites and modeled accordingly. Two Tris buffer molecules, likely acquired during 
purification, were also modeled to the Fo-Fc maps. 
In the indole-bound structure, a large difference density (Fo-Fc) greater than 3σ and 
consistent with indole was observed in the active site and was modeled accordingly. Since the 
orientation of the indole could not be determined conclusively, it was modeled in the same 
orientation as the indole ring of W33 in the wild-type β-gly structure (PDB: 2CEQ). 
In both structures disordered side chains were truncated to the point where difference 
electron density could be observed. Relevant crystallographic data are provided in Table S1.  
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Coordinates and structure factors for the apo and indole-bound crystal structures of β-gly 
W33G have been deposited with the Research Collaboratory for Structural Bioinformatics 
Protein Data Bank (PDB) with accession codes 4EAM and 4EAN, respectively. 
Results 
To test the hypothesis that protein function can be modulated through structure-based 
chemical rescue, we selected two divergent enzymes that cleave β-glycosidic bonds because of 
the ease associated with assaying the activity. While sequence-based evolutionary methods have 
proven useful in detecting energetic coupling 6,22, we instead relied on protein structure to 
identify buried tryptophan sidechains that may be serving to buttress the active site. Using 
available crystal structures 23-25, we selected Trp33 from the S. solfataricus β-glycosidase (β-gly) 
and Trp492 from E. coli β-glucuronidase (β-gluc) for testing this hypothesis (Figure 1b,c). 
While neither sidechain makes direct interactions with the substrate, each occupies a buried 
environment within 15 Å of the active site. Further, we find using modern packing metrics 26 that 
these two sidechains are among the 10% most tightly-packed buried tryptophan sidechains in the 
Protein Data Bank 27 suggesting their surroundings may be well suited to serve as indole binding 
sites. In essence, selective pressure on the amino acids surrounding each of these tryptophan 
sidechains has inadvertently evolved an optimal indole binding site given the constraints of the 
protein architecture required for function. 
We found that both β-gly W33G and β-gluc W492G exhibit strongly diminished 
β-glycosidase activity relative to their respective wild-type enzymes. Remarkably, in both cases 
addition of indole led to dose-dependent recovery of enzyme activity (Figure 1d,e). In contrast, 
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we found that addition of indole up to 15 mM, the solubility limit of indole in aqueous solution, 
did not restore activity to four separate WG point mutants of β-gly (W151G, W361G, W425G, 
W433G) or to a WG point mutant of β-gluc (W471G) if the mutation was located at the active 
site. In the presence of 5 mM indole, β-gly W33G led to product formation at a rate 0.58 times 
that of the corresponding wild-type enzyme without indole (0.34 μM/min vs. 0.58 μM/min, 
Figure 1d); in the presence of 5 mM indole β-gluc W492G led to product formation at a rate 
0.14 times that of the corresponding wild-type enzyme without indole (7.8 μM/min vs. 56 
μM/min, Figure 1e). Because rescue of β-gly W33G was more effective than β-gluc W492G at 
this indole concentration, we selected the former for further characterization. While the studies 
below serve to demonstrate that the mechanism of inactivation and rescue for β-gly W33G are as 
designed (Figure 1a), we note that in the absence of additional experiments we cannot 
definitively establish the same of β-gluc W492G. 
We first explored the mechanism of rescue by examining the rate of product formation as 
a function of both indole and substrate concentrations. In the simplest allosteric kinetic 
mechanism (Figure S2), the rate equation predicts that initial velocities as a function of substrate 
concentration can be fit to a rectangular hyperbola if the concentration of the allosteric modulator 
is fixed 28. Indeed we find this to hold across a wide range of indole concentrations, allowing us 
to fit “apparent” values of the steady-state Michaelis-Menten kinetic parameters. Individually 
fitting experimental data collected at each indole concentration, we observe a sharp decrease in 
apparent Km, from 1080 ± 30 μM without indole to 53 ± 3 μM at 10 mM indole, accompanied by 
an increase in apparent kcat, from 0.00675 ± 0.00004 s-1 without indole to 0.234 ± 0.009 s-1 at 10 
mM indole (Figure 2a,b). By contrast, the kinetic parameters of the wild-type enzyme are nearly 
indole-independent, with a Km of 58 ± 4 μM and kcat of 0.265 ± 0.002 s-1 without indole, and a Km 
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of 48 ± 1 μM and kcat of 0.221 ± 0.006 s-1 at 10 mM indole, confirming that modulation of β-gly 
W33G activity indeed relies on the WG point mutation. Notably, both Km and kcat of β-gly 
W33G reach the corresponding wild-type values at high indole concentration, suggesting that the 
rescued holo enzyme is fully functionally equivalent to the wild-type enzyme. Relative to the apo 
form of the engineered enzyme, addition of indole leads to a 20-fold decrease in Km and a 39-
fold increase in kcat; these two ratios, termed Q and W respectively 28, define the allosteric 
linkage between substrate and allosteric activator. In other words, from the value of Q we infer 
that the presence of saturating indole enhances substrate binding by -1.8 kcal/mol, or 
equivalently that the presence of saturating substrate enhances indole binding by -1.8 kcal/mol. 
Collectively, the strong linkage through both Q and W together produce a 780-fold change in the 
ratio kcat / Km upon activation by saturating concentrations of indole. 
To further test the appropriateness of this simple allosteric kinetic mechanism (Figure 
S2) for describing activation of β-gly W33G by indole, we fit the rate equation for this model 28 
to the complete set of experimentally-determined initial velocities. The limiting values of the 
Michaelis-Menten kinetic parameters for the apo and holo enzyme were set to those of the 
W33G and wild-type enzyme in the absence of indole, leaving a single free parameter in the 
fitting corresponding to the enzyme-indole dissociation constant in the absence of substrate. This 
simple kinetic model proved sufficient to describe the initial velocity across a broad range of 
indole and substrate concentrations (Figure 2c). The value of the free parameter in this optimal 
fit was 15 mM, representing the enzyme-indole dissociation constant in the absence of substrate. 
From the linkage relationship, this dissociation constant in the presence of saturating substrate 
drops to 0.75 mM. 
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To further understand the detailed mechanism for β-gly W33G rescue, we next solved the 
crystal structure of β-gly W33G to 1.7 Å resolution (Table S1). The structural basis for 
inactivation of β-gly W33G is clearly demonstrated by comparing this crystal structure to that of 
the wild-type enzyme with a substrate analog bound in the active site (Figure 3a). In the β-gly 
W33G structure, the cavity resulting from mutation of W33 to glycine is occupied by W433, a 
nearby tryptophan, which moves away from its original position near the active site. Though no 
substrate analog is present in our structure, previous studies of wild-type β-gly have highlighted 
the importance of W433 in forming a key hydrogen bond to substrate hydroxyl group 24. 
Consistent with our analysis of enzyme kinetics, studies of a closely related enzyme found that a 
synthetic substrate lacking this hydroxyl group exhibits a markedly higher Km than the 
corresponding natural substrate 29. 
To explore the basis for re-activation of β-gly W33G, we then soaked these crystals with 
indole and solved the crystal structure to 1.75 Å resolution (Table S1). Dramatically, in this 
structure we find that W433 has reverted to its original location near the active site (Figure 3b). 
As expected, we further observe clear electron density in the void left by the W33G mutation, 
which is presumably occupied by indole (Figures 3c and S3). An indole molecule modeled into 
this void fits the electron density map, which closely aligns with the W33 side chain in the wild-
type structure. Aside from very small changes near the W33G mutation, the bound and unbound 
structures are otherwise identical (0.22 Å Cα RMSD excluding residue 33). The reversion of the 
indole-bound β-gly W33G structure to match that of the wild-type enzyme is unsurprising given 
that it is fully consistent with our kinetic characterization showing complete rescue of β-gly 
W33G at high indole concentration. 
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To determine whether our engineered allosteric enzyme is active in living cells, we next 
grew E. coli cells containing expression plasmids in media supplemented with one of two 
substrates: either X-gal for qualitative (visual) detection (Figure 4a), or FDG for quantitative 
(fluorometric) detection (Figure 4b). We found that cell cultures expressing the wild-type 
enzyme retained β-glycosidase activity in the presence or absence of indole. In contrast, β-gly 
W425G, an active-site mutation that had no detectable activity in vitro (Figure S1), served as a 
negative control with no detectable activity in cell culture with or without indole. Cell cultures 
expressing β-gly W33G without the addition of indole exhibited a significant reduction in 
activity relative to the wild-type enzyme. Notably, activity in cell cultures expressing β-gly 
W33G could be rescued by addition of exogenous indole to the media (Figure 4a,b). To exclude 
the possibility that indole was disrupting cells and thus releasing β-gly W33G into the media, we 
tested for β-glycosidase activity in the media both quantitatively using FDG and qualitatively 
using X-gal. By partitioning components of these cultures we tracked β-glycosidase activity and 
found that intracellular activation of β-gly W33G was responsible for product formation (Figure 
S4). By interpolation from indole dependence of β-gly W33G determined in the analogous in 
vitro experiment (Figure 4c), we find that addition of 1.5 mM indole to the media leads to 
intracellular β-gly W33G activation commensurate with approximately 1.35 mM indole in vitro 
(Figure 4b). The extent of β-gly W33G activation, corresponding to 27% relative to the wild-
type enzyme, nearly reaches the maximal level expected at this concentration of exogenous 
indole. 
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Discussion 
In both β-gly W33G and β-gluc W492G, the structural disruption arising from the cavity-
forming mutations was transduced from a remote location to the active site, leading to 
diminished function of the engineered apo enzyme. Identifying analogous sites in other enzymes 
represents a key challenge in extending this approach to introduce allosteric control into other 
enzymes. Coevolving networks of amino acids have been used to trace energetic “wires” linking 
remote sites in proteins, which may allow rapid detection of mutations at distant regions that 
could be used to modulate protein function 6,30. Alternatively at the level of structure, 
complementary predictions may be facilitated computationally to predict whether the structural 
disruption arising from a particular cavity-forming mutation will be transduced to the active site 
31-35. From a number of studies, the identification of allosteric sites with no known natural 
effector in a variety of protein families has fueled speculation that energetic coupling of 
functional sites to remote regions of the protein may be a common phenomenon 36. The 
suggestion that proteins are “primed” to show allosteric behavior implies that the current 
challenge in engineering switchable enzymes lies not in designing allosteric mechanisms to 
transduce signals from a remote site, but rather in incorporating de novo binding sites 37. This 
view is consistent with the results presented here: the effector binding site was rationally 
designed by chemical rescue of structure, allowing allosteric modulation of enzyme activity to 
naturally emerge. 
The work presented here extends previous demonstrations of using small molecules that 
complement protein cavities as a way to control protein function 11,12. We anticipate that 
switchable enzymes can be utilized to study the biophysical properties of proteins in response to 
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cavity mutations and the subsequent binding of small molecules.  Our method measures protein 
function as the readout for binding of small molecules, as opposed to only detecting binding.  
The relative binding of various small molecules in a protein cavity can be detected and compared 
by how well they restore function, which correlates to how well they restore structure. This could 
be why our approach of rationally matching the effector to the deleted structural moiety works 
better than previous studies where they screen from a limited library of small molecules that are 
not perfectly complementary to the effector site 14. 
Structural disruption by mutation of a single buried tryptophan residue to glycine 
naturally lends itself to the use of indole as its cognate activating effector ligand. However, 
indole is a bioactive molecule present in many cell types and may prove limiting for certain 
future applications. Further, the size and chemical characteristics of indole may place intrinsic 
limits on binding affinity, manifest through the high concentrations of indole required for rescue 
in the two examples presented here. However, chemical rescue of structure need not be limited to 
this particular mutation or even to cavity-forming mutations at a single site. We anticipate that by 
identifying constellations of atoms that match a particular compound, it is possible to create 
cavities in proteins that will be complemented by larger and more diverse compounds. Slightly 
larger and more hydrophobic ligands will lead to better binding affinity, which in turn may offer 
enhanced sensitivity and selectivity. As such, we expect that chemical rescue of structure will 
represent a technique for building molecular switches and sensors that respond to a wide variety 
of activating effector ligands, including those of biological interest. Using this as a starting point, 
it may be possible to use computational protein design or directed evolution to shift the effector 
ligand to another molecule, which in turn may allow development of a number of catalytically 
amplified biosensors. 
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Figure Captions 
Figure 1: Indole rescue. (A) Mutation of a remote “buttressing” tryptophan leads to structural 
disruption of catalytic geometry, resulting in loss of activity. Subsequent addition of exogenous 
indole restores structure, and thus activity. (B) Crystal structure of β-gly with a substrate analog 
(2-deoxy-2-fluoro-glucose, purple spheres) 24, showing the “buttressing” tryptophan (Trp33, 
orange) and a nearby tryptophan (Trp433, yellow). (C) Crystal structure of β-gluc 25 with a 
substrate analog (glucaro-δ-lactam, blue spheres) showing the “buttressing” tryptophan (Trp492, 
orange). (D) Indole-dependent activity of β-gly W33G, measured spectrofluorometrically using 
100 μM fluorescein di-β-D-galactopyranoside (FDG) as a substrate. (E) Indole-dependent 
activity of β-gluc W492G, measured spectrophotometrically using 40 mM 2-nitrophenyl-β-
D-glucopyranoside (ONPGlc) as a substrate. No indole was included in data for either wild-type 
enzyme shown here. 
 
Figure 2: Rescued β-gly W33G is functionally equivalent to the wild-type enzyme. The 
apparent Michaelis-Menten parameters (A) Km and (B) kcat are presented as a function of indole 
for the wild type enzyme and W33G β-gly, measured spectrofluorometrically using FDG as a 
substrate. Parameters for wild type β-gly are essentially indole independent, and the β-gly W33G 
parameters approach the equivalent wild type values with increasing indole. Wild type and 
W33G data points overlap at 10 mM indole. Measurements were carried out in duplicate; error 
bars represent the standard error of the mean. (C) The measured initial velocities are consistent 
20 
with a simple allosteric model with one free parameter corresponding to the enzyme-indole 
dissociation constant. 
 
Figure 3: Structural basis for indole rescue of β-gly W33G. Crystal structures of apo β-gly 
W33G and indole-bound β-gly W33G were refined to 1.7 Å resolution and 1.75 Å resolution, 
respectively. Structures are superposed to the wild type enzyme (pale green) 24. A substrate 
analog (2-deoxy-2-fluoro-glucose, purple spheres) present in the structure of the wild type 
enzyme is shown to indicate the location of the active site. (A) Crystal structure of apo β-gly 
W33G (pink). Trp433 occupies the cavity produced by mutation of Trp33 to Gly, causing it to 
lose contact with the substrate. (B) Crystal structure of holo β-gly W33G (pink). Trp433 reverts 
to the conformation observed in the wild type enzyme. No other sidechains differ between the 
holo and apo structures of β-gly W33G. (C) A difference electron density (Fo-Fc) map 
contoured at 3σ from holo β-gly W33G chain A before inserting the indole. The electron density 
is consistent with indole (gray) at a location overlapping Trp33 in the wild type enzyme (pale 
green). The orientation of indole cannot be unambiguously determined at this resolution. 
 
Figure 4: Indole rescue in living cells. (A) E. coli cells expressing β-gly supplemented with X-
gal substrate for qualitative detection of activity. Addition of indole (indicated with +/-) affects 
neither wild type β-gly activity (left pair, positive control) nor β-gly W425G activity (right pair, 
negative control). Only β-gly W33G (center) shows indole-dependent activity. All tubes contain 
196 μM X-gal and 1 mM IPTG; those marked with a “+” additionally contain 2 mM indole. (B) 
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Quantification of β-gly activity in E. coli cells supplemented with FDG substrate. Fraction of 
product formation by β-gly W33G after 30 min is reported relative to wild type β-gly. Four 
experimental replicates were averaged; error bars represent the standard error. (C) The analogous 
experiment was carried out in vitro to determine the maximal activity relative to the wild type 
enzyme that could be expected from addition of 1.5 mM indole to the cell cultures. 
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Supplementary Figure Captions  
Figure S1: Indole-dependence of activity in vitro using three β-gly constructs: wild type, W33G, 
and W425G. Wild type activity does not depend on indole, W33G activity is indole dependent, 
and W425G is inactive even upon addition of indole. Product formation was measured 
spectrophotometrically using 4 mM 2-nitrophenyl-β-D-galactopyranoside as substrate. 
 
Figure S2: The simple allosteric kinetic scheme leading to the rate equation used in Figure 2c. 
 
Figure S3: A difference electron density (Fo-Fc) map contoured at 3σ from holo β-gly W33G 
chain B before inserting the indole (the equivalent map for chain A is shown in Figure 3c). 
Electron density is consistent with indole and was modeled accordingly (gray) at a location 
overlapping Trp33 in the wild type enzyme (pale orange). The orientation of the indole cannot be 
unambiguously determined at this resolution. 
 
Figure S4: Fractionation scheme used to distinguish between extracellular and intracellular 
activity. The absence of β-glycosidase activity in growth media after cells have been removed, 
even upon supplementing with indole, indicates that rescue occurs inside cells. While the rapid 
transport of indole across the E. coli cell membrane has been previously demonstrated 38, the lack 
of β-gly W33G activity in the absence of indole-supplemented media was unexpected. Indole is 
a critical signaling molecule in E. coli and a number of other bacterial species 39, yet under these 
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experimental conditions we do not observe β-gly W33G activation by either endogenous indole 
or any other structurally similar metabolites. While our inability to detect low levels of β-gly 
W33G activation by natural metabolites may be limited by the sensitivity of this crude 
biomolecular sensor, this observation may alternatively be explained by careful indole regulation 
by E. coli. Indeed, in separate experiments we find that under conditions of stress, considerably 
higher background activity can be observed. 
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Supplementary Table 
Table S1: Crystallographic data for apo β-gly W33G refined to 1.70 Å resolution and for 
indole-bound β-gly W33G refined to 1.75 Å resolution. 
 Apo W33G β-gly Indole Bound W33G β-gly 
Data Collection   
Unit-cell parameters (Å, o) a = 167.70, c = 96.40 a = 167.54, c = 95.23 
Space group P3121 P3121 
Resolution (Å)* 50.00-1.70 (1.79-1.70) 50.00-1.75 (1.84-1.75) 
Wavelength (Å) 1.0000 1.0000 
Temperature (K) 100 100 
Observed reflections 1,150,966 1,029,278 
Unique reflections 170,417 153,873 
<I/σ(I)>* 12.6 (2.2) 14.4 (2.4) 
Completeness (%)* 99.9 (100) 99.8 (100) 
Multiplicity* 6.8 (7.1) 6.7 (6.9) 
Rmerge (%)*, # 8.8 (62.7) 7.9 (64.6) 
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Rmeas*, ^ 9.5 (67.7) 8.6 (69.9) 
Rpim*, ^ 3.7 (25.4) 3.3 (26.5) 
Refinement   
Resolution (Å) 34.16-1.70 33.93-1.75 
Reflections (working/test) 161,617 / 8,526 145,752 / 7,697 
Rfactor / Rfree (%)& 16.8 / 18.6 17.4 / 19.1 
No. of atoms (protein / Cl- / 
MPD / Tris / indole / water) 
7,965 / 6 / 48 / 16 / - / 719 7,981 / 6 / 16  / - / 18 / 615 
Model Quality   
R.m.s deviations   
Bond lengths (Å) 0.010 0.010 
Bond angles (o) 1.224 1.211 
Average B factor (Å2)   
All Atoms 21.6 25.0 
Protein 20.5 24.2 
Indole - 34.4 
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*Values in parenthesis are for the highest resolution shell. 
# Rmerge = ΣhklΣi |Ii(hkl) - <I(hkl)>| / ΣhklΣi Ii(hkl), where Ii(hkl) is the intensity measured for the ith 
reflection and <I(hkl)> is the average intensity of all reflections with indices hkl.  
& Rfactor = Σhkl ||Fobs (hkl) | - |Fcalc (hkl) || / Σhkl |Fobs (hkl)|; Rfree is calculated in an identical manner 
using 5% of randomly selected reflections that were not included in the refinement 
^ Rmeas = redundancy-independent (multiplicity-weighted) Rmerge , 16. 
Rpim = precision-indicating (multiplicity-weighted) Rmerge , 40,41. 
 
Cl- 26.4 31.7 
MPD 34.7 40.1 
Tris 30.0 - 
Water 32.6 34.4 
Coordinate error based on 
Maximum Likelihood (Å) 
0.24 0.33 
Ramachandran Plot    
Favored (%) 98.0 98.3 
Allowed (%) 1.7 1.5 
